| 11066396 |
3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors |
Abbas M. Walji, Richard Berger, Craig A. Stump, Kelly-Ann S. Schlegel, James Mulhearn +3 more |
2021-07-20 |
$167,720,000 |
| 10272077 |
Piperidinone carboxamide azaindane CGRP receptor antagonists |
Ian M. Bell, Steven N. Gallicchio, Anthony Ginetti, Helen J. Mitchell, Daniel V. Paone +3 more |
2019-04-30 |
$171,965,000 |
| 9914736 |
TrKA kinase inhibitors, compositions and methods thereof |
Helen J. Mitchell, Andrew Cooke, Craig A. Stump, Xu-Fang Zhang, Casey Cameron McComas +6 more |
2018-03-13 |
$78,687,000 |
| 9862716 |
TRKA kinase inhibitors, compositions and methods thereof |
Helen J. Mitchell, Andrew Cooke, Craig A. Stump, Yi-Heng Chen, Xu-Fang Zhang +10 more |
2018-01-09 |
$60,079,000 |
| 9833448 |
Piperidinone carboxamide azaindane CGRP receptor antagonists |
Ian M. Bell, Steven N. Gallicchio, Anthony Ginnetti, Helen J. Mitchell, Daniel V. Paone +3 more |
2017-12-05 |
$49,639,000 |
| 9815846 |
TrkA kinase inhibitors, compositions and methods thereof |
Helen J. Mitchell, Andrew Cooke, Craig A. Stump, Yi-Heng Chen, Xu-Fang Zhang +13 more |
2017-11-14 |
$82,691,000 |
| 9499545 |
Piperidinone carboxamide azaindane CGRP receptor antagonists |
Ian M. Bell, Steven N. Gallicchio, Anthony Ginnetti, Helen J. Mitchell, Daniel V. Paone +3 more |
2016-11-22 |
$87,862,000 |
| 9499541 |
Piperidinone carboxamide indane CGRP receptor antagonists |
Ian M. Bell, Steven N. Gallicchio, Anthony Ginnetti, Helen J. Mitchell, Daniel V. Paone +4 more |
2016-11-22 |
$87,862,000 |
| 9296750 |
Spirolactam CGRP receptor antagonists |
Ian M. Bell, Tesfaye Biftu, Cheng Zhu, Anilkumar G. Nair |
2016-03-29 |
$130,981,000 |
| 9227972 |
Aliphatic spirolactam CGRP receptor antagonists |
Ian M. Bell, Tesfaye Biftu, Cheng Zhu, Anilkumar G. Nair, Helen J. Mitchell |
2016-01-05 |
$74,452,000 |
| 9227973 |
Pyridine CGRP receptor antagonists |
Ian M. Bell, Tesfaye Biftu, Cheng Zhu, Anilkumar G. Nair |
2016-01-05 |
$74,452,000 |
| 8993779 |
Positive allosteric modulators of MGLUR2 |
Vadim Dudkin, Kenneth L. Arrington, Mark E. Layton, Alexander Joseph Reif, Kevin J. Rodzinak +1 more |
2015-03-31 |
$66,424,000 |
| 8975286 |
Ether benzotriazole derivatives |
Vadim Dudkin, Cheng Wang, Robert M. Garbaccio, Douglas C. Beshore, Scott K. Kuduk +1 more |
2015-03-10 |
$87,534,000 |
| 8912210 |
Piperidinone carboxamide azaindane CGRP receptor antagonists |
Ian M. Bell, Steven N. Gallicchio, Anthony Ginnetti, Helen J. Mitchell, Daniel V. Paone +3 more |
2014-12-16 |
$161,344,000 |
| 8883807 |
Piperidinone carboxamide indane CGRP receptor antagonists |
Ian M. Bell, Steven N. Gallicchio, Anthony Ginnetti, Helen J. Mitchell, Daniel V. Paone +4 more |
2014-11-11 |
$48,775,000 |
| 8785481 |
Ether benzotriazole derivatives |
Douglas C. Beshore, Vadim Dudkin, Robert M. Garbaccio, Adam W. Johnson, Scott D. Kuduk +2 more |
2014-07-22 |
$76,229,000 |
| 8754096 |
Piperidinone carboxamide azaindane CGRP receptor antagonists |
Ian M. Bell, Steven N. Gallicchio, Anthony Ginnetti, Helen J. Mitchell, Daniel V. Paone +4 more |
2014-06-17 |
$87,270,000 |
| 8629275 |
AHCY hydrolase inhibitors for treatment of hyper homocysteinemia |
Antonella Converso, Timothy J. Hartingh |
2014-01-14 |
$193,016,000 |
| 8623863 |
Disubstituted azepan orexin receptor antagonists |
Paul J. Coleman, John D. Schreier |
2014-01-07 |
$63,301,000 |
| 8481556 |
Piperidinone carboxamide azaindane CGRP receptor antagonists |
Ian M. Bell |
2013-07-09 |
$144,918,000 |
| 8329697 |
Imidizo[1,2-A]pyrazines useful as AHCY hydrolase inhibitors |
Robert M. Garbaccio, Antonella Converso, Timothy J. Hartingh |
2012-12-11 |
$46,772,000 |
| 8063090 |
Mineralocorticoid receptor modulators |
Philip E. Brandish, James C. Hershey, Justin T. Steen |
2011-11-22 |
$79,793,000 |
| 8003797 |
Pyridine carboxamide orexin receptor antagonists |
Jeffrey M. Bergman, Paul J. Coleman, Swati P. Mercer, Thomas S. Reger, Anthony J. Roecker +1 more |
2011-08-23 |
$36,250,000 |
| 7732472 |
Mitotic kinesin inhibitors |
Robert M. Garbaccio, George D. Hartman |
2010-06-08 |
$47,115,000 |
| 7723365 |
Mitotic kinesin inhibitors |
Christopher D. Cox, Robert M. Garbaccio |
2010-05-25 |
$82,494,000 |
